Lam Research Corporation Reports Financial Results for the Quarter Ended December 25, 2016

FREMONT, Calif., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Lam Research Corp. (Nasdaq:LRCX) today announced financial results for the quarter ended December 25, 2016 (the "December 2016 quarter").

Highlights for the December 2016 quarter were as follows:

  • Shipments of $1.92 billion and revenue of $1.88 billion.
  • GAAP gross margin of 45.0%, GAAP operating margin of 23.4%, and GAAP diluted EPS of $1.81.
  • Non-GAAP gross margin of 46.4%, non-GAAP operating margin of 26.0%, and non-GAAP diluted EPS of $2.24.
Key Financial Data for the Quarters Ended
December 25, 2016 and September 25, 2016
(in thousands, except per-share data, percentages, and basis points)
  December 2016 September 2016 Change Q/Q
Shipments $1,922,549  $1,708,483  + 13%
Revenue $1,882,299  $1,632,419  + 15%
Gross margin as percentage of revenue 45.0% 43.9% + 110 bps
Operating margin as percentage of revenue   23.4%   19.4%   + 400 bps
Diluted EPS $1.81  $1.47  + 23%
  December 2016 September 2016 Change Q/Q
Shipments $1,922,549   $1,708,483  + 13%
Revenue $1,882,299  $1,632,419  + 15%
Gross margin as percentage of revenue 46.4% 45.2% + 120 bps
Operating margin as percentage of revenue 26.0% 22.4% + 360 bps
Diluted EPS $2.24  $1.81  + 24%

U.S. GAAP Financial Results

For the December 2016 quarter, revenue was $1,882 million, gross margin was $847 million, or 45.0% of revenue, operating expenses were $407 million, operating margin was 23.4% of revenue, and net income was $333 million, or $1.81 per diluted share on a GAAP basis. This compares to revenue of $1,632 million, gross margin of $716 million, or 43.9% of revenue, operating expenses of $400 million, operating margin of 19.4% of revenue, and net income of $264 million, or $1.47 per diluted share, for the quarter ended September 25, 2016 (the "September 2016 quarter").

Non-GAAP Financial Results

For the December 2016 quarter, non-GAAP gross margin was $874 million or 46.4% of revenue, non-GAAP operating expenses were $384 million, non-GAAP operating margin was 26.0% of revenue, and non-GAAP net income was $405 million, or $2.24 per diluted share. This compares to non-GAAP gross margin of $737 million or 45.2% of revenue, non-GAAP operating expenses of $372 million, non-GAAP operating margin of 22.4% of revenue, and non-GAAP net income of $322 million, or $1.81 per diluted share for the September 2016 quarter.

"Lam delivered another record for shipments, revenue, and net income in December, concluding a fifth consecutive year of revenue growth and outperformance when compared against the overall wafer fab equipment industry," said Martin Anstice, Lam Research's President and Chief Executive Officer. "Lam's results occur through the hard work and commitment of our employees worldwide and the increasing strategic relevance and partnership established with our customers. Looking ahead to 2017, the combination of healthy end-demand in established business segments and new application drivers are setting the course for another year of industry growth and outperformance for Lam. We are inspired by the opportunity to deliver innovation to a transforming technology industry and semiconductor ecosystem."

Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investments balances decreased to $6.1 billion at the end of the December 2016 quarter compared to $7.5 billion at the end of the September 2016 quarter. This decrease was primarily the result of approximately $1.6 billion of cash payments for the settlement of debt, combined with approximately $37 million of capital expenditures; and approximately $48 million of dividends paid to stockholders, offset by $404 million in cash flows from operating activities during the December 2016 quarter.

Deferred revenue at the end of the December 2016 quarter decreased to $673 million as compared to $704 million at the end of the September 2016 quarter. Deferred profit at the end of the December 2016 quarter decreased to $408 million as compared to $418 million at the end of the September 2016 quarter. Lam's deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to Japanese customers was approximately $129 million as of December 25, 2016 and $65 million as of September 25, 2016.

Geographic Distribution

The geographic distribution of shipments and revenue during the December 2016 quarter is shown in the following table:

RegionShipments Revenue
Taiwan37%   37%
Korea25% 26%
China8% 10%
Japan12% 8%
United States8% 7%
Europe6% 7%
Southeast Asia                                      4% 5%


For the March 2017 quarter, Lam is providing the following guidance:

 U.S. GAAP Reconciling Items Non-GAAP
Shipments$2.350 Billion +/-  $75 Million  $2.350 Billion +/-  $75 Million
Revenue$2.125 Billion+/- $75 Million      $2.125 Billion+/- $75 Million
Gross margin 44.5%+/- 1%   $21 Million  45.5%+/- 1%
Operating margin 23.8%+/- 1% $37 Million  25.5%+/- 1%
Net income per diluted share  $2.31  +/-$0.10  $37 Million $ 2.55 +/-$0.10 
Diluted share count183 Million 3 Million  180 Million

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release, and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, balance sheet valuation adjustments, financing arrangements, other investments, or other significant transactions that may be completed or determined after the date of this release. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

  • Gross margin - amortization related to intangible assets acquired in the Novellus transaction, $21 million.
  • Operating margin - amortization related to intangible assets acquired in the Novellus transaction, $37 million.
  • Earnings per share - amortization related to intangible assets acquired in the Novellus transaction, $37 million; amortization of note discounts, $6 million; and associated tax benefit for non-GAAP items ($6) million; totaling $37 million.
  • Diluted share count - impact of a note hedge issued contemporaneously with the convertible notes due 2018, 3 million shares.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company's non-GAAP results for both the December 2016 and September 2016 quarters exclude amortization related to intangible assets acquired in the Novellus transaction, costs associated with campus consolidation, the amortization of note discounts, KLA-Tencor acquisition funding net interest expense and tax benefit of non-GAAP items. Additionally, the December 2016 quarter non-GAAP results exclude costs related to the early termination of the KLA-Tencor acquisition funding, product rationalization charges and litigation settlement and the September 2016 quarter non-GAAP results exclude KLA-Tencor acquisition-related charges.

Management uses non-GAAP gross margin, operating expense, operating income, operating margin, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company's website at

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to; the estimated future revenue from shipments to Japanese customers; our revenue and industry growth and performance outlooks and their drivers: our ability to transform atomic-scale engineering and enable our customers to shape the future of technology; the legal and business factors that may affect our future tax rate; and our guidance for shipments, revenue, gross margin, operating margin, net income or earnings per diluted share, and diluted share count. Some factors that may affect these forward-looking statements include: business conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; and the actions of our customers and competitors may be inconsistent with our expectations, as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10-K for the fiscal year ended June 26, 2016 and our quarterly report on Form 10-Q for the period ended September 25, 2016. These uncertainties and changes could materially affect the forward looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

About Lam Research

Lam Research Corp. (Nasdaq:LRCX) is a trusted global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's broad portfolio of market-leading deposition, etch, and clean solutions helps customers achieve success on the wafer by enabling device features that are 1,000 times smaller than a grain of sand, resulting in smaller, faster, more powerful, and more power-efficient chips. Through collaboration, continuous innovation, and delivering on commitments, Lam is transforming atomic-scale engineering and enabling its customers to shape the future of technology. Based in Fremont, Calif., Lam Research is a Nasdaq-100 Index® and S&P 500® company whose common stock trades on the Nasdaq Global Select MarketSM under the symbol LRCX. For more information, please visit (LRCX-F).

Consolidated Financial Tables Follow.

(in thousands, except per share data and percentages)
 Three Months Ended Six Months Ended
 December 25,
 September 25,
 December 27,
 December 25,
  December 27,
Revenue$1,882,299  $1,632,419  $1,425,534  $3,514,718  $3,025,577 
Cost of goods sold1,035,502    916,222  799,024  1,951,724  1,676,704 
Gross margin846,797  716,197    626,510    1,562,994    1,348,873 
Gross margin as a percent of revenue45.0% 43.9% 43.9% 44.5% 44.6%
Research and development246,804  235,240  220,754   482,044  454,963 
Selling, general and administrative160,165  165,010  166,922  325,175  319,648 
Total operating expenses406,969  400,250  387,676  807,219  774,611 
Operating income439,828  315,947  238,834  755,775  574,262 
Operating income as a percent of revenue23.4% 19.4% 16.8% 21.5% 19.0%
Other expense, net(55,023) (23,154) (29,935) (78,177) (57,056)
Income before income taxes384,805  292,793  208,899  677,598  517,206 
Income tax (expense) benefit(52,014) (28,958) 14,081  (80,972) (5,547)
Net income$332,791  $263,835  $222,980  $596,626  $511,659 
Net income per share:         
Basic$2.05  $1.64  $1.41  $3.69  $3.23 
Diluted$1.81  $ 1.47  $1.28  $3.28  $2.94 
Number of shares used in per share calculations:         
Basic162,659  160,607  158,424  161,633  158,388 
Diluted183,543  180,017  174,242  181,780  174,308 
Cash dividend declared per common share$0.45  $0.30  $0.30  $0.75  $0.60 

(in thousands)
 December 25,
 September 25,
 June 26,
 (unaudited) (unaudited) (1) 
Cash and cash equivalents$2,503,960  $5,861,701  $5,039,322  
Investments3,329,425  1,352,775  1,788,612  
Accounts receivable, net1,426,307  1,290,317  1,262,145  
Inventories1,018,891  931,581  971,911  
Other current assets225,291  162,628   151,160 (3)
Total current assets8,503,874  9,599,002  9,213,150  
Property and equipment, net672,553  649,587  639,608  
Restricted cash and investments255,175  255,640  250,421  
Goodwill and intangible assets1,873,581  1,912,431  1,951,197  
Other assets215,876  219,702  209,939 (3)
Total assets$11,521,059  $12,636,362   $12,264,315  
Current portion of convertible notes and capital leases  $957,895  $952,999  $947,733 (3)
Other current liabilities1,700,123  1,533,253  1,470,308  
Total current liabilities2,658,018  2,486,252  2,418,041  
Long-term debt and capital leases1,768,713  3,378,179  3,378,129 (3)
Income taxes payable238,968  241,671  231,514  
Other long-term liabilities262,351  142,910  134,562  
Total liabilities4,928,050  6,249,012  6,162,246  
Temporary equity, convertible notes197,313  202,467  207,552  
Stockholders' equity (2)6,395,696  6,184,883  5,894,517  
Total liabilities and stockholders' equity$11,521,059   $12,636,362  $12,264,315  

(1)Derived from audited financial statements.
(2)Common shares issued and outstanding were 162,357 as of December 25, 2016, 161,706 as of September 25, 2016, and 160,201 as of June 26, 2016.
(3)Adjusted for effects of retrospective implementation of ASU 2015-3, regarding the simplification of the presentation of bond issuance costs, which requires that bond issuance costs related to a recognized liability be presented on the balance sheet as a direct reduction from the carrying amount of that debt liability, consistent with debt discounts.

(in thousands, unaudited)
 Three Months Ended Six Months Ended
 December 25,
 September 25,
 December 27,
 December 25,
 December 27,
Net income$332,791  $263,835  $222,980  $596,626  $511,659 
Adjustments to reconcile net income to net cash provided by operating activities:         
Depreciation and amortization77,065  74,562  71,798  151,627  142,388 
Deferred income taxes34,615  7,633  8,176  42,248   2,613 
Equity-based compensation expense32,255    38,595  32,570  70,850  68,344 
Loss on extinguishment of debt36,325        36,325   
Amortization of note discounts and issuance costs6,202  6,830  23,649  13,032    33,480 
Other, net(1,292) 16,807  10,579  15,515  20,563 
Changes in operating assets and liabilities(113,863) 64,962  (75,207) (48,901) (35,505)
Net cash provided by operating activities404,098  473,224  294,545  877,322  743,542 
Capital expenditures and intangible assets(36,513) (41,979) (28,143) (78,492) (77,597)
Net (purchase) sale of available-for-sale securities(1,990,928) 431,750  39,202  (1,559,178) 10,999 
(Issuance) repayment of notes receivable(500)   8,082  (500) 8,082 
Transfers of restricted cash and investments465  (5,219)   (4,754)  
Other, net259  (7,800) (4,746) (7,541) (6,246)
Net cash (used for) provided by investing activities(2,027,217) 376,752   14,395  (1,650,465) (64,762)
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs (1,616,270) (371) (28,374) (1,616,641) (28,470)
Treasury stock purchases(67,668) (1,854) (12,798) (69,522) (111,183)
Dividends paid(48,397) (48,052) (47,896) (96,449) (95,555 )
Reissuance of treasury stock related to employee stock purchase plan  19,320    19,320  19,245 
Proceeds from issuance of common stock3,121  1,459  1,173  4,580  1,550 
Other, net(44) (10) 2,159  (54) 5,431 
Net cash used for financing activities(1,729,258) (29,508) (85,736) (1,758,766) (208,982)
Effect of exchange rate changes on cash and cash equivalents(5,364) 1,911  344  (3,453) (3,464)
Net (decrease) increase in cash and cash equivalents(3,357,741) 822,379  223,548  (2,535,362) 466,334 
Cash and cash equivalents at beginning of period5,861,701  5,039,322  1,744,325  5,039,322  1,501,539 
Cash and cash equivalents at end of period$2,503,960  $5,861,701  $1,967,873  $2,503,960  $1,967,873 

Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
 Three Months Ended
 December 25,
 September 25,
Revenue$1,882,299  $1,632,419 
Gross margin$874,174  $737,447 
Gross margin as percentage of revenue46.4% 45.2%
Operating expenses$384,241    $371,634 
Operating income$489,933  $365,813 
Operating margin as a percentage of revenue      26.0% 22.4%
Net income$405,190  $322,074 
Net income per diluted share$2.24  $1.81 
Shares used in per share calculation - diluted180,613  177,628 

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income and U.S. GAAP number of dilutive shares to Non-GAAP number of dilutive shares
(in thousands, except per share data)
 Three Months Ended
 December 25,
 September 25,
U.S. GAAP net income$332,791  $263,835 
Pre-tax non-GAAP items:   
Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold21,250  21,250 
Product rationalization - cost of goods sold6,127   
Costs associated with campus consolidation - research and development995  2,561 
Product rationalization - research and development1,650   
Amortization related to intangible assets acquired in Novellus transaction - selling, general and administrative16,083  16,083 
KLA-Tencor acquisition-related costs - selling, general and administrative  9,972 
Litigation settlement - selling general and administrative4,000   
KLA-Tencor acquisition funding interest expense, net - other expense, net2,682  17,709 
Amortization of note discounts - other expense, net5,671  5,913 
Costs related to early termination of KLA-Tencor acquisition funding - other expense, net34,518   
Net income tax benefit on non-GAAP items(20,577) (15,249)
Non-GAAP net income$405,190  $322,074 
Non-GAAP net income per diluted share$2.24    $1.81 
U.S. GAAP number of shares used for per diluted share calculation183,543  180,017 
Effect of convertible note hedge(2,930) (2,389)
Non-GAAP number of shares used for per diluted share calculation180,613  177,628 

Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
 Three Months Ended
 December 25,
  September 25,
U.S. GAAP gross margin$846,797  $716,197 
Pre-tax non-GAAP items:     
Amortization related to intangible assets acquired in Novellus transaction        21,250  21,250 
Product rationalization$ 6,127  $ 
Non-GAAP gross margin$874,174  $737,447 
U.S. GAAP gross margin as a percentage of revenue45.0% 43.9%
Non-GAAP gross margin as a percentage of revenue46.4% 45.2%
U.S. GAAP operating expenses$406,969  $400,250 
Pre-tax non-GAAP items:   
Amortization related to intangible assets acquired in Novellus transaction(16,083) (16,083)
KLA-Tencor acquisition-related costs  (9,972)
Costs associated with campus consolidation(995) (2,561)
Product rationalization(1,650)  
Litigation settlement(4,000)  
Non-GAAP operating expenses$384,241   $371,634 
Non-GAAP operating income$489,933  $365,813 
GAAP operating margin as percent of revenue23.4% 19.4%
Non-GAAP operating margin as a percent of revenue26.0% 22.4%
Lam Research Corporation Contacts:

Satya Kumar, Investor Relations, phone: 510-572-1615, e-mail:

Primary Logo

Source: Lam Research

News Provided by Acquire Media

circle-arrow2 circle-arrow2 facebook google handshake2 health2 linkedin menu pdf plant2 search twitter youtube